The Future of GDNF in Parkinson's Disease

The Future of GDNF in Parkinson's Disease

Bibliographic Details
Main Authors: Fredric P. Manfredsson, Nicole K. Polinski, Thyagarajan Subramanian, Nicholas Boulis, Dustin R. Wakeman, Ronald J. Mandel
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-12-01
Series:Frontiers in Aging Neuroscience
Subjects:
Parkinson's disease
gene therapy (GT)
neurotrophic factor
neurturin
clinical trial (2.172)
GDNF (glial cell line-derived neurotrophic factor)
Online Access:https://www.frontiersin.org/articles/10.3389/fnagi.2020.593572/full
id doaj-e1776ee5c46742d6bccf0fa8834b726c
record_format Article
spelling doaj-e1776ee5c46742d6bccf0fa8834b726c2020-12-08T08:33:23ZengFrontiers Media S.A.Frontiers in Aging Neuroscience1663-43652020-12-011210.3389/fnagi.2020.593572593572The Future of GDNF in Parkinson's DiseaseFredric P. Manfredsson0Nicole K. Polinski1Thyagarajan Subramanian2Nicholas Boulis3Dustin R. Wakeman4Dustin R. Wakeman5Ronald J. Mandel6Department of Neurobiology, Barrow Neurological Institute, Phoenix, AZ, United StatesThe Michael J. Fox Foundation for Parkinson's Research, New York, NY, United StatesDepartment of Neurology and Neural and Behavioral Sciences, Penn State University College of Medicine, Hershey, PA, United StatesDepartment of Neurosurgery, Emory University, Atlanta, GA, United StatesVirscio, Inc., New Haven, CT, United StatesDepartment of Psychiatry, Yale School of Medicine, New Haven, CT, United StatesDepartment of Neuroscience, University of Florida, Gainesville, FL, United Stateshttps://www.frontiersin.org/articles/10.3389/fnagi.2020.593572/fullParkinson's diseasegene therapy (GT)neurotrophic factorneurturinclinical trial (2.172)GDNF (glial cell line-derived neurotrophic factor)
collection DOAJ
language English
format Article
sources DOAJ
author Fredric P. Manfredsson
Nicole K. Polinski
Thyagarajan Subramanian
Nicholas Boulis
Dustin R. Wakeman
Dustin R. Wakeman
Ronald J. Mandel
spellingShingle Fredric P. Manfredsson
Nicole K. Polinski
Thyagarajan Subramanian
Nicholas Boulis
Dustin R. Wakeman
Dustin R. Wakeman
Ronald J. Mandel
The Future of GDNF in Parkinson's Disease
Frontiers in Aging Neuroscience
Parkinson's disease
gene therapy (GT)
neurotrophic factor
neurturin
clinical trial (2.172)
GDNF (glial cell line-derived neurotrophic factor)
author_facet Fredric P. Manfredsson
Nicole K. Polinski
Thyagarajan Subramanian
Nicholas Boulis
Dustin R. Wakeman
Dustin R. Wakeman
Ronald J. Mandel
author_sort Fredric P. Manfredsson
title The Future of GDNF in Parkinson's Disease
title_short The Future of GDNF in Parkinson's Disease
title_full The Future of GDNF in Parkinson's Disease
title_fullStr The Future of GDNF in Parkinson's Disease
title_full_unstemmed The Future of GDNF in Parkinson's Disease
title_sort future of gdnf in parkinson's disease
publisher Frontiers Media S.A.
series Frontiers in Aging Neuroscience
issn 1663-4365
publishDate 2020-12-01
topic Parkinson's disease
gene therapy (GT)
neurotrophic factor
neurturin
clinical trial (2.172)
GDNF (glial cell line-derived neurotrophic factor)
url https://www.frontiersin.org/articles/10.3389/fnagi.2020.593572/full
work_keys_str_mv AT fredricpmanfredsson thefutureofgdnfinparkinsonsdisease
AT nicolekpolinski thefutureofgdnfinparkinsonsdisease
AT thyagarajansubramanian thefutureofgdnfinparkinsonsdisease
AT nicholasboulis thefutureofgdnfinparkinsonsdisease
AT dustinrwakeman thefutureofgdnfinparkinsonsdisease
AT dustinrwakeman thefutureofgdnfinparkinsonsdisease
AT ronaldjmandel thefutureofgdnfinparkinsonsdisease
AT fredricpmanfredsson futureofgdnfinparkinsonsdisease
AT nicolekpolinski futureofgdnfinparkinsonsdisease
AT thyagarajansubramanian futureofgdnfinparkinsonsdisease
AT nicholasboulis futureofgdnfinparkinsonsdisease
AT dustinrwakeman futureofgdnfinparkinsonsdisease
AT dustinrwakeman futureofgdnfinparkinsonsdisease
AT ronaldjmandel futureofgdnfinparkinsonsdisease
_version_ 1724391118527791104

Similar Items